{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:53:10Z","timestamp":1791978790209,"version":"4.4.0"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jtct.2026.09.028","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:27:45Z","timestamp":1789662465000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of a Pharmacist-Driven Survivorship Clinic on Adherence to Screening and Preventive Care after Allogeneic Hematopoietic Cell Transplant"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7228-6421","authenticated-orcid":false,"given":"Kelsea","family":"Seago","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Autumn","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3456-1186","authenticated-orcid":false,"given":"Spencer K.","family":"Yingling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Dillaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Veltri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9776-4802","authenticated-orcid":false,"given":"Aaron","family":"Cumpston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jtct.2026.09.028_bib0001","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bbmt.2020.04.013","article-title":"Current use of and trends in hematopoietic cell transplantation in the United States","volume":"26","author":"D'Souza","year":"2020","journal-title":"Biol Blood Marrow Transplant."},{"issue":"4","key":"10.1016\/j.jtct.2026.09.028_bib0002","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.hemonc.2017.05.009","article-title":"Long-term complications after hematopoietic cell transplantation","volume":"10","author":"Majhail","year":"2017","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1016\/j.jtct.2026.09.028_bib0003","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.bbmt.2011.12.519","article-title":"Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation","volume":"18","author":"Majhail","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jtct.2026.09.028_bib0004","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/bmt.2012.258","article-title":"Surviving the cure: long term followup of hematopoietic cell transplant recipients","volume":"48","author":"Majhail","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"16","key":"10.1016\/j.jtct.2026.09.028_bib0005","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1200\/JCO.2010.33.7212","article-title":"Long-term survival and late deaths after allogeneic hematopoietic cell transplantation","volume":"29","author":"Wingard","year":"2011","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.jtct.2026.09.028_bib0006","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/bmt.2015.63","article-title":"Secondary solid cancer screening following hematopoietic cell transplantation","volume":"50","author":"Inamoto","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jtct.2026.09.028_bib0007","doi-asserted-by":"crossref","DOI":"10.6004\/jnccn.2025.0047","article-title":"Hematopoietic Cell Transplantation, Version 3.2025, NCCN Clinical Practice Guidelines in Oncology","volume":"23","author":"Loren","year":"2025","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jtct.2026.09.028_bib0008","unstructured":"Foundation for the Accreditation of Cellular Therapy (FACT); Joint Accreditation Committee of ISCT and EBMT (JACIE). International Standards for Hematopoietic Cellular Therapy Product Collection, Processing, and Administration. 7th ed. Version 7.0. Omaha, NE: Foundation for the Accreditation of Cellular Therapy and Joint Accreditation Committee\u2013ISCT & EBMT; March 2018"},{"key":"10.1016\/j.jtct.2026.09.028_bib0009","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2147\/JBM.S206027","article-title":"Optimal delivery of follow-up care after allogeneic hematopoietic stem-cell transplant: improving patient outcomes with a multidisciplinary approach","volume":"11","author":"Giaccone","year":"2020","journal-title":"J Blood Med"},{"issue":"4","key":"10.1016\/j.jtct.2026.09.028_bib0010","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jtct.2023.12.001","article-title":"International recommendations for screening and preventative practices of long-term survivors of transplantation and cellular therapy: a 2023 update","volume":"30","author":"Rotz","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"6","key":"10.1016\/j.jtct.2026.09.028_bib0011","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.bbmt.2018.03.023","article-title":"ASBMT Practice Guidelines Committee survey on long-term follow-up clinics for hematopoietic cell transplant survivors","volume":"24","author":"Hashmi","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2026.09.028_bib0012","doi-asserted-by":"crossref","first-page":"30","DOI":"10.7326\/M15-3058","article-title":"Pharmacist-led chronic disease management: a systematic review of effectiveness and harms compared with usual care","volume":"165","author":"Greer","year":"2016","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.jtct.2026.09.028_bib0013","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.japh.2020.12.005","article-title":"Pharmacist-led collaborative medication management programs for oral antineoplastic therapies: a systematic literature review","volume":"61","author":"Passey","year":"2021","journal-title":"J Am Pharm Assoc"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726007578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726007578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:34:01Z","timestamp":1791977641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726007578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":13,"alternative-id":["S2666636726007578"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.09.028","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of a Pharmacist-Driven Survivorship Clinic on Adherence to Screening and Preventive Care after Allogeneic Hematopoietic Cell Transplant","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.09.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}